Parvovirus B19 infection in HIV patient with pure red cell aplasia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 5, 2005, Pages 1216-1220

  Sanphasitvong, Wanviput ^a   Poovorawan, Kittiyod ^a   Boonsuk, Pitirat ^a   Assanasen, Thamathorn ^a   Nakorn, Thanyaphong Na ^a   Poovorawan, Yong ^a,b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30344432713     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997; 176: 269-73.
2. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 15: 926-33.
3. Hawkins CC, Gold JW, Whimbey E, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 184-8.
4. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000; 59: 672-83.
5. Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. Am J Hematol 1998; 58: 95-9.
6. Mitchell SA, Welch JM, Weston-Smith S, Nicholson F, Bradbeer CS. Parvovirus infection and anaemia in a patient with AIDS: case report. Genitourin Med 1990; 66: 95-6.
7. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000; 12: 289-94.
8. Mylonakis E, Dickinson BP, Mileno MD, et al. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy. Am J Hematol 1999; 60: 164-6.
9. Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998; 24: 375-401.
10. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986; 22: 883-6.
11. Poovorawan Y, Theamboonlers A, Suandork P, Hirsch P. Prevalence of antibodies to parvovirus B 19 in Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 422-4.
12. Portmore AC. Parvoviruses (erythema infectiosum, aplasatic crisis). In: Mandell GL, Bennett JE, Dolin R. eds. Mandell, Douglas and Bennett's Principles and practice of infectious diseases. Vol 2. 4th ed. New York, NY: Churchill Livingstone. 1995: 1439-46.
13. Suandork P, Theamboonlers A, Likitnukul S, Hirsch P, Poovorawan Y. Parvovirus B19 antibodies in immunocompromized children in Thailand. Asian Pac J Allergy Immunol 2000; 18: 161-4.
14. Wills TS, Nadler JP, Somboonwit C, et al. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read 2004; 14: 313-5.
15. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-97.
16. Zerbini M, Gallinella G, Cricca M, Bonvicini F, Musiani M. Diagnostic procedures in B19 infection. Pathol Biol (Paris) 2002; 50: 332-8.
17. Zolnourian ZR, Curran MD, Rima BK, Coyle PV, O'Neill HJ, Middleton D. Parvovirus B19 in kidney transplant patients. Transplantation 2000; 69: 2198-202.